JSPR
Jasper Therapeutics Inc
0.5854$
+3.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -803.1% | – | – | – | -1,800.2% | – | – | – | – | – | – | – | |
| – | 13.8% | – | – | – | 20.9% | – | – | – | – | – | – | – | |
| – | 56.4% | – | – | – | 167.8% | – | – | – | – | – | – | – | |
| – | -69.3% | – | – | – | 70.8% | – | – | – | – | – | – | – | |
| – | 11.2% | – | – | – | 8.2% | – | – | – | – | – | – | – | |
| – | -11.2% | – | – | – | -6.5% | – | – | – | – | – | – | – | |
| – | 0.0% | – | – | – | 26.8% | – | – | – | – | – | – | – | |
| – | -13.2% | – | – | – | 29.4% | – | – | – | – | – | – | – | |
| – | -827.5% | – | – | – | -1,777.3% | – | – | – | – | – | – | – | |
| – | -814.3% | – | – | – | -1,808.3% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.